Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 59 checked references that resolve
resolves10.1038/nrc.2017.17Prospects for combining targeted and conventional cancer therapy with immunotherapy
resolves10.1038/nm1100Cancer immunotherapy: moving beyond current vaccines
resolves10.1038/nri3191Adoptive immunotherapy for cancer: harnessing the T cell response
resolves10.1038/nature13988Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
resolves10.1038/nrc3239The blockade of immune checkpoints in cancer immunotherapy
resolves10.1002/adma.201506312Inflammation‐Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti‐PD1 Antibody
resolves10.1002/adfm.201603651Immune Complexes Mimicking Synthetic Vaccine Nanoparticles for Enhanced Migration and Cross‐Presentation of Dendritic Cells
resolves10.1038/ncomms13193Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
resolves10.1126/science.aaa3828A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
resolves10.1021/nl500618uCancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
resolves10.1021/jacs.6b09538Photodynamic Therapy Mediated by Nontoxic Core–Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer
resolves10.1038/ncomms14754Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
resolves10.1158/1078-0432.CCR-13-3271Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
resolves10.1038/nature13954PD-1 blockade induces responses by inhibiting adaptive immune resistance
resolves10.1126/science.aaa1348Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
resolves10.1038/ncomms12499Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
resolves10.1002/adfm.201703303Nutlin‐3a and Cytokine Co‐loaded Spermine‐Modified Acetalated Dextran Nanoparticles for Cancer Chemo‐Immunotherapy
resolves10.1016/j.biomaterials.2014.08.036Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy
resolves10.1021/nn5002112Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles
resolves10.1021/ja402015sSelf-Assembly of Amphiphilic Plasmonic Micelle-Like Nanoparticles in Selective Solvents
resolves10.1002/adma.201603114Gd‐Hybridized Plasmonic Au‐Nanocomposites Enhanced Tumor‐Interior Drug Permeability in Multimodal Imaging‐Guided Therapy
resolves10.1002/adma.201601710DNA‐Nanostructure–Gold‐Nanorod Hybrids for Enhanced In Vivo Optoacoustic Imaging and Photothermal Therapy
resolves10.1039/C6TC01499BEmpirical structural design of core@shell Au@Ag nanoparticles for SERS applications
resolves10.1021/jacs.5b07973Post-Synthesis Incorporation of <sup>64</sup>Cu in CuS Nanocrystals to Radiolabel Photothermal Probes: A Feasible Approach for Clinics
resolves10.1002/adma.201602193Ambient Aqueous Synthesis of Ultrasmall PEGylated Cu<sub>2−</sub><i><sub>x</sub></i>Se Nanoparticles as a Multifunctional Theranostic Agent for Multimodal Imaging Guided Photothermal Therapy of Cancer
resolves10.1021/nn500722yMultifunctional Fe<sub>3</sub>O<sub>4</sub>@Polydopamine Core–Shell Nanocomposites for Intracellular mRNA Detection and Imaging-Guided Photothermal Therapy
resolves10.1021/acsami.6b07997Fe<sub>3</sub>O<sub>4</sub>@polydopamine Composite Theranostic Superparticles Employing Preassembled Fe<sub>3</sub>O<sub>4</sub> Nanoparticles as the Core
resolves10.1039/c2cc31354eMonodisperse inorganic supraparticles: formation mechanism, properties and applications
resolves10.1002/adma.201601498Hierarchical Targeting Strategy for Enhanced Tumor Tissue Accumulation/Retention and Cellular Internalization
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.